Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Am J Prev Med. 2017 Sep;53(3):275-281. doi: 10.1016/j.amepre.2017.03.012. Epub 2017 May 15.
The recently updated U.S. National HIV/AIDS Strategy sets key HIV prevention and care targets for 2020, but the trajectory of the epidemic remains unclear. Authors modeled HIV incidence, prevalence, and mortality for the U.S. over 10 years to determine whether an ambitious trajectory toward "ending AIDS" by 2025 would be achievable.
Authors utilized recently published 2010-2013 Centers for Disease Control and Prevention surveillance data to model HIV incidence, prevalence, and mortality. Authors applied a 90/90/90 framework (90% awareness of serostatus, 90% of diagnosed individuals in care, and 90% of individuals on antiretroviral therapy virally suppressed) by 2020 and 95/95/95 by 2025 to assess the feasibility of meeting epidemiologic targets. Analyses were conducted in 2016.
With a goal of reducing infections to 21,000 new HIV infections in 2020, authors project a transmission rate of 1.74, 12,571 deaths, and a total of 1,205,515 people living with HIV. By 2025, with a target of 12,000 new HIV infections (a 69% decrease in HIV incidence), authors project a transmission rate of 0.98, 12,522 deaths, and a total of 1,220,615 people living with HIV. With a 90/90/90 framework by 2020 and a 95/95/95 framework by 2025, these epidemiologic targets would be feasible.
Key programmatic milestones provide an ambitious, but important, pathway to reduce U.S. HIV incidence below 12,000 new infections by 2025. HIV incidence would decrease below mortality in 2025, marking a transition toward ending the HIV/AIDS epidemic. Such goals will require a sustained and intensified national commitment over the next decade.
最近更新的美国国家艾滋病病毒/艾滋病战略为 2020 年设定了关键的艾滋病毒预防和护理目标,但疫情的轨迹仍不清楚。作者对美国未来 10 年的艾滋病毒发病率、流行率和死亡率进行建模,以确定到 2025 年实现“终结艾滋病”的宏伟目标是否可行。
作者利用最近公布的 2010-2013 年疾病控制和预防中心监测数据对艾滋病毒发病率、流行率和死亡率进行建模。作者应用 2020 年 90/90/90 框架(90%知晓血清状况、90%诊断为艾滋病患者接受治疗、90%接受抗逆转录病毒治疗的患者病毒得到抑制)和 2025 年 95/95/95 框架来评估实现流行病学目标的可行性。分析于 2016 年进行。
设定到 2020 年将新感染艾滋病毒的人数减少到 21,000 人,作者预计传播率为 1.74,12571 人死亡,共有 1205515 人携带艾滋病毒。到 2025 年,目标是将新感染艾滋病毒的人数减少到 12000 人(艾滋病毒发病率下降 69%),作者预计传播率为 0.98,12522 人死亡,共有 1220615 人携带艾滋病毒。到 2020 年达到 90/90/90 框架,到 2025 年达到 95/95/95 框架,这些流行病学目标是可行的。
关键的方案里程碑为到 2025 年将美国艾滋病毒发病率降低到 12000 例以下提供了一个雄心勃勃但重要的途径。到 2025 年,艾滋病毒发病率将低于死亡率,标志着艾滋病疫情结束的过渡。这些目标将需要未来十年持续和加强国家承诺。